Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.

Published in:

Cancers, 2023, v. 15, n. 12, p. 3180, doi. 10.3390/cancers15123180

By:

• Marin-Acevedo, Julian A.;
• Withycombe, Bethany M.;
• Kim, Youngchul;
• Brohl, Andrew S.;
• Eroglu, Zeynep;
• Markowitz, Joseph;
• Tarhini, Ahmad A.;
• Tsai, Kenneth Y.;
• Khushalani, Nikhil I.

Publication type:

Article